Health Canada inspection
Ranbaxy Pharmaceuticals Canada Inc. (a SUN PHARMA Company): Health Canada inspection of Sep 15, 2023
Health Canada · GVP · rating C
Key facts
| Establishment | Ranbaxy Pharmaceuticals Canada Inc. (a SUN PHARMA Company) |
|---|---|
| City | Brampton |
| Province | Ontario |
| Country | Canada |
| Program | GVP |
| Start date | Sep 11, 2023 |
| End date | Sep 15, 2023 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 101281 |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.
Source: Health Canada, Drug and Health Product Inspections. Contains information licensed under the Open Government Licence – Canada · Source date: